| abstract |
The present disclosure relates to a pharmaceutical biodegradable/bioerodible aqueous gel system optionally comprising an active pharmaceutical ingredient, wherein the pharmaceutical composition transitions from a liquid to a gel near the body temperature of a mammal. Such compositions may include reversible gelling materials such as rheology modifiers such as methylcellulose and citrate. |